On June 16, Senate Finance Committee Ranking Member Ron Wyden (D-OR) released a request for information (RFI) on proposals aimed at lowering the cost of prescription drugs. The RFI specifically sought policy proposals to lower the price manufacturers charge for prescription drugs; lower out-of-pocket costs for patients; and foster biopharmaceutical innovation, clinical trials, and scientific talent development. The drug pricing RFI is the first in a series of requests by Senate Finance Democrats geared toward developing concrete legislative proposals in the near future. On Aug. 17, AMCP submitted comments in response to the drug pricing RFI.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
